Cyclacel Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
21 Dec 23 | Buy€18,305 | Spiro Rombotis | Individual | 6,070 | €3.02 | |
21 Dec 23 | Buy€5,688 | Paul McBarron | Individual | 1,886 | €3.02 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 83,347 | 4.22% |
Hedge Funds | 134,000 | 6.79% |
Institutions | 295,600 | 15% |
General Public | 1,461,257 | 74% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 134.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
134,000 | €112.5k | 0% | no data | |||
102,250 | €85.8k | 0% | 0.51% | |||
82,032 | €68.9k | 0% | 0.03% | |||
37,979 | €31.9k | 686% | no data | |||
30,000 | €25.2k | 1.18% | no data | |||
16,707 | €14.0k | 167% | no data | |||
16,241 | €13.6k | 1.15% | no data | |||
15,333 | €12.9k | 0% | no data | |||
14,285 | €12.0k | 0% | no data | |||
12,255 | €10.3k | 0% | no data | |||
10,694 | €9.0k | 0% | no data | |||
8,313 | €7.0k | 2.43% | no data | |||
5,796 | €4.9k | 0% | no data | |||
4,207 | €3.5k | 0.62% | no data | |||
4,155 | €3.5k | 0% | no data | |||
4,089 | €3.4k | 0% | no data | |||
4,073 | €3.4k | 0% | no data | |||
3,875 | €3.3k | 63.3% | no data | |||
3,513 | €2.9k | -16.1% | no data | |||
1,900 | €1.6k | 0% | no data | |||
832 | €698.3 | 0% | no data | |||
133 | €111.7 | 0% | no data | |||
126 | €105.7 | 0% | no data | |||
80 | €67.1 | 0% | no data | |||
33 | €27.7 | 0% | no data |